baber/WOPTO huggingface dataset:
Patent PT-2517813-E (PT)
Title: Cutting tool having releasably mounted self-clamping cutting head
Inventor: HECHT GIL
IPC: B23B51/02
Filed: 2009-11-19
Abstract: A cutting tool (10) has a tool shank (14) and a replaceable cutting head (12) resiliently secured to the tool shank (14) by an interference fit between a male fixation member (24) of the cutting head (12) and a female fixation member (88) of the tool shank (14). The male fixation member (24) has a resilience slit (28). In each cross section of the cutting tool (10) taken perpendicular to an axis of rotation (L) of the cutting tool (10) through mutual abutment regions (100), the cross sectional profiles of the mutual abutment regions (100) are arcuate sectors.
Patent PT-590455-E (PT)
Inventor: LANG HANS-JOCHEN
IPC: C07D413/04
Filed: 1993-09-20
Abstract: Described are guanidinocarbonyl isoquinolines I, <CHEM> with R(1) hydrogen, (amino)(cyclo)(aryl)alk(en)yl, (heteroaryl); R(2) hydrogen, halogen, alkyl, or Aryl; G <CHEM> X(2), X(3) and X(4) hydrogen, halogen, nitro, amino, alkyl, sulfonamide, (mono)(di)(lower alkyl)(amino), benzyloxy, hydroxy; X(1) hydrogen, oxygen, sulfur and NR(7)R(8), and their pharmaceutically acceptable salts; described is also the process for their prepara-tion, their use as medicaments, and medicaments containing them for treating congestive heart failure, arrhythmic conditions as well as cardioprotective agents in mammals.
Patent PT-664894-E (PT)
Inventor: MARGULIS WALTER
IPC: G02B6/12
Filed: 1994-08-15
Abstract: PCT No. PCT/SE94/00745 Sec. 371 Date Jun. 14, 1995 Sec. 102(e) Date Jun. 14, 1995 PCT Filed Aug. 15, 1994 PCT Pub. No. WO95/05617 PCT Pub. Date Feb. 23, 1995An optical device includes a waveguide and a film or layer of a material having highly nonlinear optical characteristics, in particular a semiconductor material. The film is located so close to the waveguide core that the evanescent field of light propagating along the waveguide extends up to the film. In this optical device, the large nonlinear properties of the material influence the optical characteristics of the waveguide. When positioned along a similar D-fiber, the device can be used as a fiber-based, nonlinear coupler controlled by a relatively weak light signal. The same device can be used as an element of a laser and in a number of various other applications.
Patent PT-682026-E (PT)
Inventor: MUELLER HANS RUDOLF
IPC: A61P17/06
Filed: 1995-04-27
Abstract: Crystalline (6S)-tetrahydrofolic acid (Ia) and crystalline (6R)-tetrahydrofolic acid (Ib) are new.
Patent PT-795326-E (PT)
Inventor: YANAGISAWA HIROAKI
IPC: C07D403/10
Filed: 1995-03-16
Abstract: Use, in the manufacture of a medicament suitable for local application to the eyes for use in combination with a  beta -blocker for the treatment of ocular hypertension and/or glaucoma, of a compound of general formula (I): <CHEM>  wherein:   R<1> represents alkyl, alkenyl or a group of formula R<5>-A-B- (R<5> represents hydrogen, alkyl, cycloalkyl or aliphatic acyl, A represents oxygen or sulfur, and B represents a single bond or alkylene); R<2> represents alkyl, alkenyl or a group of formula -C(R<6>)(R<7>)(R<8>) (R<6> represents hydroxyl or alkoxy, and R<7> and R<8> represent hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl or aralkyl); R<3> represents carboxyl or a group of formula -CON(R<9>)(R<10>) (R<9> and R<10> represent hydrogen or alkyl optionally substituted by 1 to 3 substituents from Substituent group (I)); and optionally substituted by 1 to 3 substituents from Substituent group (I)); and   R<4> represents carboxyl, carboxycarbonyl or tetrazol-5-yl; substituent group (I): aryl, 5- or 6-membered heteroaromatic ring group, halogen, hydroxyl, alkoxy, carboxyl, alkoxycarbonyl, amino, aliphatic acylamide and aromatic acylamide.
Patent PT-748286-E (PT)
Inventor: COBBEN JOHANNES IGNATIUS MARIE
IPC: B42D15/10
Filed: 1995-03-29
Abstract: PCT No. PCT/NL95/00119 Sec. 371 Date Nov. 21, 1996 Sec. 102(e) Date Nov. 21, 1996 PCT Filed Mar. 29, 1995 PCT Pub. No. WO95/26274 PCT Pub. Date Oct. 5, 1995The invention relates to a carrier representing value provided with recognizable pattern, for instance in the form of giro checks, bankchecks, banknotes, shares, bonds and other documents representing a value, wherein the patterns are formed by parts treated by means of a laser beam. This object is reached in that the patterns have been provided by means of a laser light beam. The use of a laser beam makes it possible to apply particularly fine structures which either cannot be applied with other treating methods, or only with the greatest financial effort. The use of laser beams enables variation of the width or depth of the channels or perforations which is almost impossible with other treating methods.
Patent PT-723962-E (PT)
Inventor: JONAS ROCHUS
IPC: C07D285/16
Filed: 1996-01-15
Abstract: 3-Arylalkyl-5-phenyl-3,6-dihydro-1,3,4-thiadiazin-2-one derivs. of formula (I) and their salts and enantiomers are new. R1, R2 = H or A; R3, R4 = OH, OR10, SR10, SOR10, SO2R10, Hal, methylenedioxy, NO2, NH2, NHR10 or NR10R11; R5 = phenyl opt. mono- or disubstd. by R6 and/or R7; Q = direct bond or 1-6C alkylene; R6, R7 = NH2, NR8R9, NHR10, NR10R11, NO2, Hal, CN, OA, COOH or COOA; R8, R9 = H; 1-8C acyl opt. substd. by 1-5 F and/or Cl; COOA; SA; SOA; SO2A; CONH2; CONHA; CONA2; COCOOH; COCOOA; COCONH2; COCONHA; or COCONA2; A = 1-6C alkyl opt. substd. by 1-5 F and/or Cl; R10, R11 = A, 3-7C cycloalkyl, 4-8C methylene-cycloalkyl or 2-8C alkenyl; Hal = F, Cl, Br or I.
Patent PT-830061-E (PT)
Inventor: BLACKBURN PETER
IPC: A01N63/50
Filed: 1996-06-07
Abstract: Disclosed are novel, moist paper or fabric wipes containing a bacteriocin disinfectant formulation, which have a low alcohol content and which afford rapid, one-step disinfection and drying of surfaces. Also disclosed is a method of disinfection and drying of skin, including cow teat skin, either prior to or after milking, which employs the wipes.
Patent PT-837989-E (PT)
Inventor: HARMAN JAYDEN DAVID
IPC: F04D29/28
Filed: 1996-07-08
Abstract: PCT No. PCT/AU96/00427 Sec. 371 Date Feb. 17, 1998 Sec. 102(e) Date Feb. 17, 1998 PCT Filed Jul. 8, 1996 PCT Pub. No. WO97/03291 PCT Pub. Date Jan. 30, 1997A rotor (18) for use with a fluid flow generator or reactor, the rotor being intended to rotate about a central axis (19) and having a surface which defines an arcuate fluid pathway for fluid flow about the central axis about which the rotor is able to rotate, wherein the surface has the configuration of a logarithmic curve substantially conforming to the mathematical progression known as the Golden Section or the Fibonacci Progression.
Patent PT-897003-E (PT)
Inventor: BROEK PETER VAN DEN
IPC: C12N1/15
Filed: 1997-07-05
Abstract: The present invention has for object a koji mold which is capable to express at least 2 times more endo- and exo-peptidases than the wild type strain Aspergillus oryzae CNCM I-1882, and especially at least 30 mU of endopeptidase activity, at least 30 mU of leucine-amino-peptidase activity and at least 10 mU of prolyl-dipeptidyl-peptidase activity per ml of supernatant when grown in a minimal medium containing 0.2% soy bean proteins. The invention also provides a DNA-binding protein of Aspergillus oryzae (AREA) having at least the amino-acid sequence from amino-acid 1 to amino-acid 731 of SEQ ID NO:2 or functional derivatives thereof. The invention also provides a DNA molecule that comprises an areA gene encoding the DNA-binding protein according to the invention. In a fourth aspect, the invention provides a method for over-producing proteolytic enzymes, comprising cultivating a koji mold according to the invention in a suitable growth medium under conditions that the mold expresses enzymes, and optionally isolating the enzymes in the form of a concentrate. In another aspect, the invention provides the use of the koji mold of the invention to hydrolyze protein-containing materials. In a last further aspect, the invention provides a food product comprising a protein hydrolysate obtainable by fermentation with a koji mold of the invention of a material comprising proteins and at least 5mM of L-glutamine.
Patent PT-889875-E (PT)
Inventor: CLARE MICHAEL
IPC: A61K31/195
Filed: 1997-03-20
Abstract: The present invention relates to a class of compounds represented by the Formula I   <IMAGE>   or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the  alpha v beta 3 integrin.
Patent PT-956774-E (PT)
Title: Edible fats containing arachidonic acid and foods containing the same
Inventor: AKIMOTO KENGO
IPC: A23L1/30
Filed: 1997-10-09
Abstract: Edible oil containing arachidonic acid obtained from microorganisms belonging to the subgenus  Mortierella  of the genus  Mortierella  and being capable of producing arachidonic acid are provided. The oil contain little unsaponifiable matters and, above all, the smallest possible amount of sterol with cyclopropane structure which have not been recognized as food components, and are suitable for the production of foods, in particular, infant formula.  Arachidonic acid-containing edible oil originating in microorganisms containing not more than 0.8% by weight, preferably not more than 0.6% by weight of unsaponifiable matters and 20% by weight or more of arachidonic acid. Further, these edible oil contain not more than 0.3% by weight, preferably not more than 0.15% by weight of 24,25-methylenecholest-5-en-3  ²  -ol. The microorganisms are those belonging to the subgenus  Mortierella  of the genus  Mortierella  and being capable of producing arachidonic acid. These microorganisms belong to the species  alpina  of the genus  Mortierella.  Foods including the arachidonic acid-containing edible oil. Formula for premature infants, formula for infants, foods for infants, and foods for pregnant women and nursing mothers, including the arachidonic acid-containing edible oil.
Patent PT-946563-E (PT)
Inventor: MAURER ANDREAS
IPC: C07D487/22
Filed: 1997-11-21
Abstract: The invention concerns a method of obtaining haemin. In order to separate haemin from the globin part, slaughter blood is subjected to an acid treatment at a pH of between 1.2 and 3 and a temperature of between 45 and 80° C., the haemin then being separated from globin.
Patent IE-850224-L (IE)
Title: Epoxy resin composition and use in laminated printed circuit¹board
IPC: C08J5/24
Filed: 1985-01-30
Abstract: An epoxy resin composition and a process for preparing electrical laminates therefrom has been disclosed. 
<??>The epoxy resin composition is comprised of an epoxy resin, a solvent and a hardener which is the reaction product of a hexa-alkyl ether of a methylol melamine having the general formula: 
<CHEM>
 wherein each R, independently, is an alkyl radical having from 1 to 4 carbon atoms with a polyhydric phenol and, optionally, a monohydric phenol, with the phenol compound(s) having been employed in an amount to provide a ratio of at least one reactive phenolic hyxroxy group for each alkoxy group.
Patent IE-810278-L (IE)
Title: Fibre-reinforced composition
IPC: C04B14/38
Filed: 1981-02-13
Abstract: Asbestos-free, fiber-reinforced, hydraulically setting compositions can be processed to fiber-reinforced shaped articles. The compositions are obtained by mixing fibers, hydraulic binders and water-soluble or water-emulsifiable polymers and by adding a metallic compound, particularly a metal salt or hydroxide. The composition can be processed in the equipment conventionally used in the asbestos cement industry.
[US4339273A]
Patent IE-39419-L (IE)
Title: Bis-(benzyl) acetic acid derivatives.
IPC: C07C67/00
Filed: 1974-02-19
Abstract: 1453643 Bis(p - acyl - benzyl) - acetic acids and -malonic acid esters SANDOZ Ltd 15 Feb 1974 [20 Feb 1973 3 Oct 1973] 6953/74 Heading C2C The invention comprises novel compounds of the Formula I in which R 1 is hydrogen, fluorine, chlorine, or straight chain C 1-4 alkoxy, R 2 is methyl or ethyl, R 3 is methyl or ethyl wherein each R 1 , R 2 and/ or R 3 may be the same or different and either (i) X is hydrogen and Y is COOH or (ii) both X and Y are COOR 4 wherein each R 4 is C 1-4 alkyl provided that when the R 1 's are hydrogen and the R 2 's and R 3 's are methyl, both R 4 's are not ethyl, and salts of (i). The compounds (ii) may be prepared by reacting a compound of the Formula III wherein X is bromine or chlorine with a compound of the Formula IV wherein D is an alkali metal and the compounds (i) may be prepared by hydrolysis followed by decarboxylation of the compounds (1). α-Bromo-p-pivaloyltoluene may be prepared by forming a Grignard reagent from 4-bromotoluene and reacting it with pivaloyl chloride to yield p-pivaloyltoluene followed by free radical bromination. Pharmaceutical compositions of the compounds I when administered orally with the usual excipients show hypolipidemic and especially hypolipoproteinemic activity.
[GB1453643A]
Patent IE-850477-L (IE)
Title: Self-tuning coin tester
IPC: G07F9/04
Filed: 1985-02-26
Abstract: A self-tuning coin testing apparatus having a coin sensor circuit which produces an output signal indicative of a parameter characteristic of the coins which are tested by the coin sensor and a programmed microprocessor which stores an initial acceptance limit, determines whether the output signal from the coin sensor is indicative of a valid coin, stores a signal based on the output signal for each valid coin, calculates a statistical function based on the stored signal, and finally computes and stores a new acceptance limit based on the stored signals for a predetermined number of previously accepted coins. The statistical function, is preferably weighted so that it is based upon values for only a predetermined number of the most recently accepted coins so that a recent average is maintained.
Patent IE-43598-L (IE)
Title: Erythromycin derivatives
IPC: C07H17/08
Filed: 1976-04-07
Abstract: The invention relates to novel erythromycin derivatives, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as antibacterials.
[US4048306A]
Patent FI-830229-L (FI)
Inventor: LEUTWYLER ROBERT
IPC: F16K11/10
Filed: 1983-01-24
Abstract: 1. Double-seat pneumatic valve, especially for rail vehicles, for example for actuating a current collector, an anti-slip device, or a sanding device, said valve comprising : - a movable valve plunger (11) ; - a valve body (13, 14) which is rigidly attached to the valve plunger (II) and possesses two sealing rings (23, 24) which protrude radially and are held in a manner such that they are axially spaced ; - two stationary valve seats (25, 26) which face one another and severally cooperate with one of the sealing rings (23, 24), these valve seats (25, 26) severally encircling a through-opening from a middle valve chamber (C) to an outer valve chamber (B, D), the diameter of the valve body (13, 14) being smaller than that of the through-openings ; - two rings (27, 28) which are installed on the valve body (13, 14), between the sealing rings (23, 24), in a manner such that they can be moved by sliding, a spring (29), installed between these rings (27, 28), causing them to press the two sealing rings (23, 24) onto the valve seats (25, 26) when the double-seat valve is in the neutral position, while in each of the opening positions the two rings (27, 28) limit the valve travel as a result of coming into contact with one another, characterized - in that the sealing rings (23, 24) are inset into peripheral grooves (21, 22) in the valve body (13, 14) ; - in that each of the peripheral grooves (21, 22) has a chamfer (31) on one side, this chamfer (31) serving as a supporting surface for the inset sealing ring (23, 24), and - in that each of the spring-loaded rings (27, 28) has a flange (30) which points radially inwards and bears against the valve body (13, 14) in order to limit its sliding movement thereon, in the direction of the valve seat (25, 26).
Patent FI-832121-L (FI)
Inventor: WEISS JOERN-VOLKER
IPC: C04B24/28
Filed: 1983-06-13
Abstract: An epoxy resin-polyammonium salt emulsion is based on a liquid epoxy resin, a latent curing agent, an emulsifier, and water, wherein (a) the emulsifier is a primary aliphatic alcohol of 12-14 carbon atoms, an adduct thereof with up to 5 ethylene oxide groups, or a carboxylic acid polyglycol ester, and (b) the latent curing agent is the reaction product obtained by complete neutralization of oxalic acid with a polyamine of the formula H2N-CH2-CH2-NH-hd xH  wherein X=2, 3, or 4 or with a reaction product, containing amino groups, of a reaction of this polyamine with fatty acids.
Patent IE-41145-L (IE)
Title: Pyroglutamyl compounds
IPC: C07K1/113
Filed: 1975-05-13
Abstract: Novel pyroglutamyl compounds of the formula I <IMAGE> in which X denotes an optionally branched alkyl radical having 2 to 6 carbon atoms or an optionally branched alkyl radical having 2 to 6 carbon atoms which is either substituted in the alpha -position by a carbamoyl group or in the omega -position by a carbamoyl group or a carboxyl group, are prepared by reaction of a pyroglutamic acid, which is optionally substituted on the nitrogen by a benzyloxycarbonyl radical, or of a reactive derivative thereof with a primary amine which introduces the group X and subsequent removal of possible carboxyl protective groups. The novel compounds are useful therapeutics for the treatment of psychic disorders, in particular of depressions.
Patent IE-43483-L (IE)
Title: Thiopyrano-pyrazoles
IPC: A61K31/415
Filed: 1976-06-29
Abstract: QA87 Anti-inflammatory activity and hypotensive activity are exhibited by compounds having the formula the salts thereof, and the 5-oxide and 5,5-dioxide thereof, wherein A is a straight or branched chain alkylene group; R1 is hydrogen, alkyl, alkoxy, trifluoromethyl, or halogen; R2 is hydrogen or alkyl; and R3 is hydrogen, alkyl, phenyl, or phenylalkyl.
[CA1072100A]
Patent IE-871429-L (IE)
Title: Ppg 1800 antifoam agent.
IPC: A61K47/00
Filed: 1987-05-29
Abstract: There is described the use of ethylene oxide/propylene oxide block copolymers in the control of foam in pharmaceutical preparations, in particular those for parenteral application, and furthermore liquid pharmaceutical preparations and their production.
Patent IE-811494-L (IE)
Title: Aminocyclopentanone amides
IPC: C07C405/00
Filed: 1981-07-03
Abstract: Compounds are described of the formula <IMAGE> (1) in which R1 is unsubstituted or substituted phenylalkyl, thienylalkyl or naphthylalkyl, or cinnamyl; R2 is a hydrogen atom, methyl or alkyl substituted by alkoxy or -COOH; W is alkylene; X is cis or trans -CH=CH- or -CH2CH2-; and Y is a saturated heterocyclic amino group having 5-8 ring members; and their salts and solvates. These compounds inhibit blood platelet aggregation and bronchoconstriction and may be formulated for use as antithrombotic and anti-asthmatic agents.
[US4371530A]
Patent IE-36827-L (IE)
Title: Extrusion head for forming plastics netting.
IPC: B29C48/315
Filed: 1972-11-06
Abstract: A continuous extrusion machine for manufacturing a net like mesh: the machine includes a circular housing having first and second adjacent outlets near its base; one extrusion outlet includes means for extruding longitudinal ribs which means is replaceably fastened at the end of the housing; the other extrusion outlet is shaped to produce transverse ribs and to deposit the transverse ribs on the longitudinal ribs; each outlet communicates with a separate extrusion pressure chamber, whereby two different materials may be extruded; blocking means at the exterior of the housing are shifted between a position which blocks the second outlet and one which opens the second outlet, thereby selectively cutting off or permitting flow out the second outlet to produce spaced transverse ribs.
[US3791784A]
Patent IE-36879-L (IE)
Title: Cephalosporins
IPC: C07D499/00
Filed: 1972-11-22
Abstract: 1381339 Cephalosporins ELI LILLY & CO 22 Nov 1972 [30 Nov 1971 (2)] 53968/72 Heading C2C A process for preventing reversion of an imino halide of a 7-acylamidodesacetoxycephalosporinate ester of the formula where R is the residue of an acyl group and R 5 is the residue of an ester group, to a 7-acylamidodesacetoxycephalosporinate ester of the formula during treatment of the imino halide with an alcohol or thiol for the production of 7-aminodesacetoxycephalosporinate ester hydrohalides, comprises reacting the imino halide in an inert organic liquid diluent in the presence of hydrogen halide with alcohols or thiols of formulµ or wherein X represents 0 or 5; each of Y and Z is alkyl such that the alcohol or thiol has from 4 to 12 carbon atoms; or Y and Z are taken together with the carbon atom to which they are bonded to denote a cycloalkyl group having from 5 to 8 ring-forming carbon atoms; each of W and Z<SP>1</SP> is H or C 1 -C 2 alkyl, and each of R 1 and R 2 is H or a hydrocarbon moiety such that the 1,3-diol has from 3 to 15 carbon atoms; and each of R 3 and R 4 is H or alkyl such that the molecule has from 2 to 12 carbon atoms. The imino chloride of 4-nitrobenzyl 7-phenoxy-acetamido - 3 - methyl - 3 - cephem - 4 - carboxylate is prepared by reaction of 4-nitrobenzyl 7- phenoxyacetamido - 3 - methyl - 3 - cephem- 4-carboxylate with PCl 5 .
[GB1381339A]
Patent IE-37193-L (IE)
Title: Anthracene derivatives
IPC: A61P17/00
Filed: 1972-11-23
Abstract: 1361879 Benzoyl esters of 1,8,9-anthracenetriols STERLING WINTHROP GROUP Ltd 23 Nov 1972 [26 Nov 1971] 54927/71 Heading C2C [Also in Division A5] Novel substituted-benzoyl esters of a 1,8,9- anthracenetriol are prepared by reaction of an appropriate 1,8,9-anthracenetriol with a benzoic acid or a functional derivative thereof (preferably the acid chloride) in an inert solvent, in the presence of a catalyst (preferably a nitrogenous base) and under an inert atmosphere. The esters have the general Formula (I) in which each R is hydrogen or an X, Y-substituted benzoyl group and at least one R is the said benzoyl group. X is halogen, hydroxy, nitro, alkyl, alkoxy, aryloxy trifluoromethyl or an optionally substituted alkyl- or aryl-carboxy group, Y is hydrogen or X and R 1 is hydrogen or methyl. Compounds prepared are the tribenzoyl esters in which Y is hydrogen X is nitro, hydroxymethyl, acetoxy or chloro and R 1 is hydrogen and also 1,8,9-tri-(2-hydroxy-benzoyloxy)-3-methyl-anthracene and the mono- or di- (2-acetoxy-benzoyl)esters of 1,8,9-anthracenetriol. These anthracene derivatives are useful in treating inflammatory conditions of the skin and form with a suitable vehicle a pharmaceutical composition which may be administered topically. The composition may also contain salicylic acid and/or hydrocortisone.
[GB1361879A]